Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2023

Stockholders' Equity Note [Abstract]

Schedule of Common Stock Outstanding Roll Forward

The Company has 50,000,000 shares of no par value common stock authorized. The following table presents a rollforward of changes in common shares issued and outstanding.


	Quarter Ended September 30,		Nine Months Ended September 30,
(shares in ones)	2023	2022	2023	2022
Issued and outstanding common shares, beginning of period	13,284,998	13,537,895	13,422,692	13,631,740
Issuance of common shares	3,007	694	5,475	2,886
Repurchase of common shares	(56,483)	(67,696)	(196,645)	(163,733)
Issued and outstanding common shares, end of period	13,231,522	13,470,893	13,231,522	13,470,893

Schedule Of Net Income (Loss) Per Common Share

The following table presents net income (loss) per common share and diluted net income (loss) per common share.


	Quarter Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share amounts)	2023		2022		2023		2022
Net income (loss) to common shareholders	$	42,591	$	59,594	$	1,208,754	$	(925,943)
Adjustment of redeemable noncontrolling interests	(628)		(17,730)		7,087		(62,168)
Adjusted net income (loss) to common shareholders	$	41,963	$	41,864	$	1,215,841	$	(988,111)

Basic common shares outstanding	13,315		13,564		13,382		13,609

Dilutive potential common shares from restricted stock units and restricted stock (1)	30		31		24		—
Diluted common shares outstanding	13,345		13,595		13,406		13,609
Basic net income (loss) per common share	$	3.15	$	3.09	$	90.86	$	(72.61)
Diluted net income (loss) per common share (1)	$	3.14	$	3.08	$	90.69	$	(72.61)

(1) The impact of 28 thousand shares from restricted stock units and restricted stock was excluded from the computation of diluted net loss per common share for the nine months ended September 30, 2022 because the effect would have been anti-dilutive.